富鲁达(Fluidigm) 与罗氏(Roche)联合发表声明会共同进行Roche 454生命科学GS FLX 和 GS 高级测序系统与Fluidigm Access Array 第二代测序样本制备系统在全球的促销活动。
Fluidigm Access Array 是第二代测序样本制备的理想系统，在短短3小时内能制备48个测序文库，即进行48个样品x48个扩增点，2,304个反应。大大简化测序前测序样本的制备和测序工具的利用效率。
Roche and Fluidigm jointly announced today that the firms will co-promote Roche 454 Life Sciences' GS FLX and GS Junior sequencing systems with Fluidigm's Access Array System.
The firms said that the partnership will offer a "robust and streamlined workflow," minimizing the manual steps required for targeted sequencing applications including genotyping and rare variant detection. Financial and other terms of the alliance were not disclosed.
Christopher McLeod, president and CEO of 454 Life Sciences, said in a statement that the firms' respective technologies are "extremely complementary, allowing analysis of large numbers of sample/amplicon combinations in an affordable workflow, without the need for complicated liquid handling.
"In essence, a single Access Array plate on a single GS Junior System run generates as much data as hundreds, even thousands, of 96-well plates analyzed on a capillary sequencing system," he added.
Fluidigm's Access Array System can automate processing of 48 unique samples against 48 unique amplicons, resulting in PCR products which are ready for emPCR amplification, the partners said.
Related Stories
扫一扫即可访问手机版展台